Manual on the proper use of meta-[(211)At] astato-benzylguanidine ([(211)At] MABG) injections in clinical trials for targeted alpha therapy (1st edition)

In this manuscript, we present the guideline for use of meta-[(211)At] astatobenzylguanidine ([(211)At] MABG), a newly introduced alpha emitting radiopharmaceutical to the up-coming World’s first clinical trial for targeted alpha therapy (TAT) at Fukushima Medical University in Japan, focusing on ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Ukon, Naoyuki, Higashi, Tatsuya, Hosono, Makoto, Kinuya, Seigo, Yamada, Takahiro, Yanagida, Sachiko, Namba, Masao, Nakamura, Yoshihide
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304041/
https://www.ncbi.nlm.nih.gov/pubmed/35794455
http://dx.doi.org/10.1007/s12149-022-01765-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304041/
https://www.ncbi.nlm.nih.gov/pubmed/35794455
http://dx.doi.org/10.1007/s12149-022-01765-1

Ejemplares similares